|
Volumn 130, Issue 1, 2014, Pages 71-72
|
Lubiprostone for treatment-resistant constipation associated with clozapine use
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISACODYL;
CLOZAPINE;
DOCUSATE SODIUM;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
HISTAMINE H1 RECEPTOR;
ISPAGULA;
LACTULOSE;
LAMOTRIGINE;
LUBIPROSTONE;
MACROGOL 3350;
MAGNESIUM CITRATE;
OLANZAPINE;
PHENYTOIN;
RISPERIDONE;
TIOTIXENE;
VALPROATE SEMISODIUM;
CHLORIDE CHANNEL STIMULATING AGENT;
NEUROLEPTIC AGENT;
PROSTAGLANDIN E1;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
BEDTIME DOSAGE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
CONSTIPATION;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
DRUG MONITORING;
DRUG USE;
DRUG WITHDRAWAL;
FECES IMPACTION;
GASTROINTESTINAL MOTILITY;
HUMAN;
LEUKOCYTOCLASTIC VASCULITIS;
LONG TERM CARE;
NAUSEA AND VOMITING;
PNEUMONIA;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
SCHIZOPHRENIA;
SEIZURE;
SEPSIS;
SMALL INTESTINE OBSTRUCTION;
SMOKING BAN;
VIOLENCE;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
MALE;
TREATMENT FAILURE;
ADULT;
ALPROSTADIL;
ANTIPSYCHOTIC AGENTS;
CHLORIDE CHANNEL AGONISTS;
CLOZAPINE;
CONSTIPATION;
HUMANS;
MALE;
SCHIZOPHRENIA;
TREATMENT FAILURE;
|
EID: 84901984587
PISSN: 0001690X
EISSN: 16000447
Source Type: Journal
DOI: 10.1111/acps.12259 Document Type: Article |
Times cited : (15)
|
References (5)
|